- Home
- ABVC vs CLST Comparison
ABVC vs CLST Comparison
Compare ABVC & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- CLST
- Stock Information
- Founded
- ABVC 2015
- CLST 1922
- Country
- ABVC United States
- CLST United States
- Employees
- ABVC N/A
- CLST N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- CLST
- Sector
- ABVC Health Care
- CLST
- Exchange
- ABVC Nasdaq
- CLST Nasdaq
- Market Cap
- ABVC 52.1M
- CLST 52.5M
- IPO Year
- ABVC N/A
- CLST N/A
- Fundamental
- Price
- ABVC $2.72
- CLST $13.06
- Analyst Decision
- ABVC
- CLST
- Analyst Count
- ABVC 0
- CLST 0
- Target Price
- ABVC N/A
- CLST N/A
- AVG Volume (30 Days)
- ABVC 117.4K
- CLST 2.7K
- Earning Date
- ABVC 08-13-2025
- CLST 10-23-2025
- Dividend Yield
- ABVC N/A
- CLST N/A
- EPS Growth
- ABVC N/A
- CLST N/A
- EPS
- ABVC N/A
- CLST 0.58
- Revenue
- ABVC $391,242.00
- CLST $11,354,000.00
- Revenue This Year
- ABVC $735.18
- CLST N/A
- Revenue Next Year
- ABVC N/A
- CLST N/A
- P/E Ratio
- ABVC N/A
- CLST $22.67
- Revenue Growth
- ABVC 186.84
- CLST 164.54
- 52 Week Low
- ABVC $0.40
- CLST $10.67
- 52 Week High
- ABVC $5.48
- CLST $14.23
- Technical
- Relative Strength Index (RSI)
- ABVC 45.17
- CLST 67.19
- Support Level
- ABVC $2.51
- CLST $12.66
- Resistance Level
- ABVC $3.14
- CLST $13.22
- Average True Range (ATR)
- ABVC 0.21
- CLST 0.16
- MACD
- ABVC -0.04
- CLST 0.04
- Stochastic Oscillator
- ABVC 24.85
- CLST 89.75
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.